195 related articles for article (PubMed ID: 21943126)
1. A comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective function.
Sargsyan SA; Blackburn DJ; Barber SC; Grosskreutz J; De Vos KJ; Monk PN; Shaw PJ
BMC Neurosci; 2011 Sep; 12():91. PubMed ID: 21943126
[TBL] [Abstract][Full Text] [Related]
2. Ablation of interleukin-19 improves motor function in a mouse model of amyotrophic lateral sclerosis.
Komiya H; Takeuchi H; Ogawa Y; Suzuki K; Ogasawara A; Takahashi K; Azuma YT; Doi H; Tanaka F
Mol Brain; 2021 Apr; 14(1):74. PubMed ID: 33931083
[TBL] [Abstract][Full Text] [Related]
3. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
[TBL] [Abstract][Full Text] [Related]
5. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.
Turner BJ; Ackerley S; Davies KE; Talbot K
Hum Mol Genet; 2010 Mar; 19(5):815-24. PubMed ID: 20008901
[TBL] [Abstract][Full Text] [Related]
6. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
Apolloni S; Fabbrizio P; Amadio S; Volonté C
J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
[TBL] [Abstract][Full Text] [Related]
7. Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.
Banerjee R; Mosley RL; Reynolds AD; Dhar A; Jackson-Lewis V; Gordon PH; Przedborski S; Gendelman HE
PLoS One; 2008 Jul; 3(7):e2740. PubMed ID: 18648532
[TBL] [Abstract][Full Text] [Related]
8. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
[TBL] [Abstract][Full Text] [Related]
9. CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)
Silverman JM; Christy D; Shyu CC; Moon KM; Fernando S; Gidden Z; Cowan CM; Ban Y; Stacey RG; Grad LI; McAlary L; Mackenzie IR; Foster LJ; Cashman NR
J Biol Chem; 2019 Mar; 294(10):3744-3759. PubMed ID: 30635404
[TBL] [Abstract][Full Text] [Related]
10. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
11. IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1.
Gravel M; Béland LC; Soucy G; Abdelhamid E; Rahimian R; Gravel C; Kriz J
J Neurosci; 2016 Jan; 36(3):1031-48. PubMed ID: 26791230
[TBL] [Abstract][Full Text] [Related]
12. The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis.
Apolloni S; Parisi C; Pesaresi MG; Rossi S; Carrì MT; Cozzolino M; Volonté C; D'Ambrosi N
J Immunol; 2013 May; 190(10):5187-95. PubMed ID: 23589615
[TBL] [Abstract][Full Text] [Related]
13. Replacement of microglial cells using Clodronate liposome and bone marrow transplantation in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis.
Lee JC; Seong J; Kim SH; Lee SJ; Cho YJ; An J; Nam DH; Joo KM; Cha CI
Biochem Biophys Res Commun; 2012 Feb; 418(2):359-65. PubMed ID: 22269142
[TBL] [Abstract][Full Text] [Related]
14. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP
J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883
[TBL] [Abstract][Full Text] [Related]
15. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
Kim J; Kim TY; Cho KS; Kim HN; Koh JY
Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
[TBL] [Abstract][Full Text] [Related]
16. Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1.
Sargsyan SA; Blackburn DJ; Barber SC; Monk PN; Shaw PJ
Neuroreport; 2009 Oct; 20(16):1450-5. PubMed ID: 19752764
[TBL] [Abstract][Full Text] [Related]
17. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis.
Beers DR; Henkel JS; Xiao Q; Zhao W; Wang J; Yen AA; Siklos L; McKercher SR; Appel SH
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):16021-6. PubMed ID: 17043238
[TBL] [Abstract][Full Text] [Related]
18. Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS.
Dibaj P; Zschüntzsch J; Steffens H; Scheffel J; Göricke B; Weishaupt JH; Le Meur K; Kirchhoff F; Hanisch UK; Schomburg ED; Neusch C
PLoS One; 2012; 7(8):e43963. PubMed ID: 22952827
[TBL] [Abstract][Full Text] [Related]
19. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
